Drug Delivery Nanoparticles Formulation
Related Sections-Services
CD Bioparticles’ services with customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms can help you to solve:
The challenges you might meet:
-
Drugs/Active pharmaceutical ingredient (API) which are hard to be dispersed or dissolved in different solvent systems
-
Limited options for drug/API encapsulation into different formats (size, structure, crystallization)
-
Limited options of drug/API loading carriers for different types of drugs/API
-
Low specificity of the targeting
-
High dosage required for treatment
-
High side-effect of the toxic chemotherapeutic agents
-
Tedious materials synthesis, modification, and production
Figure 1. Nanoparticle types that can be custom developed.
Key features:
-
Excellular vesicle/Exosomes Production
-
Exosome-Mimetic Nanovesicles Production
-
Mesenchymal Stem Cell (MSC) Exosomes Biological Function
-
Liposomes Production
-
Conventional Liposomes Production
-
Immunoliposomes (Ligand-Targeted Liposomes) Production
-
PEGylated Liposomes Production
-
Pharmacosomes Production
-
Solid Lipid Nanoparticle Production
-
Transfersomes and Ethosomes Production
-
Cationic Nanoemulsions Production
-
Lipid Nanoparticle Production
-
Nanostructured Lipid Carriers Production
-
Nanocages Production
-
Nanocapsules Production
-
Microcapsule Production
-
Micelles Productions
-
Metallic Nanoparticles Production
-
Carbon-based Nanocages Production
-
Cyclodextrin production
-
Polymeric Nanoparticles Production
-
Protein-based Nanoparticles Production
-
Molecular Motor production
-
Living Cell-Based Drug Delivery Systems
-
Peptide-Based Drug Delivery Systems
-
Viral Vector-Based Delivery System
-
Adeno-Associated Virus Vectors
-
Adenovirus Vectors
-
HSV Vectors
-
Lentiviral Vectors
-
Retroviral Vectors
-
VSV Vectors
Key benefits:
-
Wide coverage of the biocompatible drug-delivery system for different dosage forms for different administration routes, such as oral formulation, injection formulation, cutaneous formulation, mucosal formulation, and inhalation formulation.
-
Drug-oriented, customized drug-delivery system production and formulation improves the delivery efficiency of the drugs, such as small molecules, nucleic acids, or peptides
-
Improving the drug/API absorption/penetration/targeting, as well as the stability
-
Ready-to-use drug-delivery systems
-
Post-loadable drug-delivery systems simplifying your loading process, improving your API loading yield in a controllable way
-
Adaptable building blocks for customized formulation
-
Analytical platforms cover from drug-delivery system fabrications to in-vitro and in-vivo tests
-
From pre-formulation to GMP process, promising the quality of products
Application candidates:
-
Nanoparticles with low targeting efficiency and low targeting specificity
-
Cell specific, or tissue specific targeted delivery
-
Non-invasive therapy or minimally invasive therapy
-
Programmable delivery
-
Drugs/API delivery with different administration routes